Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Case-Control Study of the Efficacy of EsoGuard on Samples Collected Using EsoCheck, Versus Esophagogastroduodenoscopy, for the Diagnosis of Barrett's Esophagus With and Without Dysplasia, and for Esophageal Adenocarcinoma

NCT04295811 is registered in ClinicalTrials.gov with Lucid Diagnostics, Inc. as lead sponsor.

NCT NCT04295811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04295811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Case-Control Study of the Efficacy of EsoGuard on Samples Collected Using EsoCheck, Versus Esophagogastroduodenoscopy, for the Diagnosis of Barrett's Esophagus With and Without Dysplasia, and for Esophageal Adenocarcinoma
Lead sponsor
Lucid Diagnostics, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 18, 2020
Completion date
June 1, 2027
Enrollment
784 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

barrett esophagus, barrett's esophagus without dysplasia, barretts esophagus with dysplasia, esophageal adenocarcinoma